FDA Inspection 1080428 — NewYork-Presbyterian/Weill Cornell Medical Center

NewYork-Presbyterian/Weill Cornell Medical Center — FEI 2470926

The FDA completed an inspection of NewYork-Presbyterian/Weill Cornell Medical Center on February 7, 2019 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)